HIKMA Pharmaceuticals
HIK · London Stock Exchange (primary) / ASE (secondary) · Pharmaceuticals · 美国上市: HKMPY
公司简介
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman in 1978 that has grown into one of the world's leading generic drug manufacturers, with primary listing on the London Stock Exchange. The company manufactures injectables, branded generics, and proprietary drugs sold across the Middle East, North Africa, the US, and Europe. While its primary market is London (HIK LN), it maintains historical and operational roots in Jordan.
| 交易所 | London Stock Exchange (primary) / ASE (secondary) |
| 股票代码 | HIK |
| 行业 | Pharmaceuticals |
| 美国上市 | HKMPY |
| 参考市值 美元 | $4.20B |
| 网站 | 访问官网 |
实时报价
正在加载实时价格……
| 市值 | |
| 当日区间 | |
| 52周区间 |
购买渠道
在美国以HKMPY交易——可通过大多数美国券商账户购买。
在其本地市场（London Stock Exchange (primary) / ASE (secondary)），可通过以下提供该交易所准入的全球券商进行投资：
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Amman Stock Exchange — 官方交易所上市信息
仅为准入信息参考，不构成推荐或购买要约。请向您的券商确认资格、费用及当前可用性。
Jordan的其他公司
公司数据及任何实时价格均为参考性质，可能存在延迟或不准确，仅供研究参考，不构成投资建议。请以交易所、公司公告及您的券商信息为准。